Zosano Pharma Corporation ZSAN
Day range unavailable
52-week range unavailable
- Market cap
- 2.73M
- Revenue (ttm)
- 659.00K
- Shares out
- 4.90M
- Forward P/E
- -6.20
- Beta
- 3.29
- Analysts
- Hold
- Price target
- 21.00 (+3666.1%)
- Earnings date
- May 13, 2022
Key statistics
- Enterprise value
- -4.66M
- PEG ratio
- 0.00
- Price / sales
- 4.15
- Price / book
- 0.19
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -48.80%
- Free cash flow
- -18.03M
- Total cash
- 13.53M
- Total debt
- 6.04M
- Return on equity
- -192.97%
- Short % of float
- 8.17%
- 50-day average
- 1.53
- 200-day average
- 0.92973
Analyst view
Consensus: hold
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
May 13, 2022
Expected May 13, 2022. Consensus EPS estimate -0.02.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 13, 2022 | Mar 1, 2022 | 0.00 | — | — | — |
| Mar 17, 2022 | Dec 1, 2021 | -2.45 | — | — | — |
| Nov 10, 2021 | Sep 1, 2021 | -2.45 | — | — | — |
| Aug 10, 2021 | Jun 1, 2021 | -2.45 | — | — | — |
| May 12, 2021 | Mar 1, 2021 | -2.45 | — | — | — |
| Mar 11, 2021 | Dec 1, 2020 | -2.45 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 23, 2022 | BTIG | down | Buy | Neutral |
| Mar 15, 2021 | Maxim Group | main | — | Buy |
| Nov 25, 2020 | HC Wainwright & Co. | main | — | Buy |
| Oct 2, 2020 | HC Wainwright & Co. | main | — | Buy |
| Apr 9, 2020 | H.C. Wainwright | init | — | Buy |
| Mar 27, 2020 | BTIG | main | — | Buy |
About Zosano Pharma Corporation
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- zosanopharma.com
News
81 Biggest Movers From Yesterday
93 Biggest Movers From Friday
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Tuesday
Stocks That Hit 52-Week Lows On Monday
60 Biggest Movers From Yesterday
88 Biggest Movers From Yesterday
48 Stocks Moving in Tuesday's Pre-Market Session
Stocks That Hit 52-Week Highs On Tuesday
77 Biggest Movers From Yesterday
Your note
Sign in to keep a note on ZSAN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ELMS STEVEN A | Director | Stock Award(Grant) | Jun 9, 2021 | 2,740,730 |
| GRAIS LINDA S | Director | Stock Award(Grant) | Jun 9, 2021 | 22,500 |
| GREATHOUSE KENNETH R | Director | Sale | Nov 22, 2021 | 43,500 |
| HAGAN JOSEPH PATRICK | Director | Stock Award(Grant) | Jun 9, 2021 | 22,500 |
| KELLERMAN DONALD J | Officer | Sale | Mar 30, 2022 | 56,331 |
| LEWIS HAYLEY | Officer | Sale | Jun 3, 2021 | 49,779 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Geode Capital Management, LLC | 18.37% | 900,316 | 7.09M | Mar 30, 2022 |
| Vanguard Group, Inc. (The) | 3.00% | 147,109 | 1.16M | Mar 30, 2022 |
| Aisling Capital Management LP | 1.58% | 77,662 | 611.59K | Mar 30, 2022 |
| Blackrock Inc. | 1.20% | 58,602 | 461.49K | Mar 30, 2022 |
| State Street Corporation | 0.25% | 12,467 | 98.18K | Mar 30, 2022 |
| Renaissance Technologies, LLC | 0.15% | 7,115 | 56.03K | Mar 30, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.84% | 90,042 | 709.08K | Mar 30, 2022 |
| Vanguard Extended Market Index Fund | 0.98% | 47,964 | 377.72K | Mar 30, 2022 |
| Fidelity Extended Market Index Fund | 0.32% | 15,802 | 124.44K | Mar 30, 2022 |
| Vanguard Institutional Index-Inst Total Stock Market Ind | 0.08% | 4,093 | 32.23K | Mar 30, 2022 |
| Vanguard Balanced Index Fund | 0.08% | 3,745 | 29.49K | Mar 30, 2022 |
| Fidelity Total Market Index Fund | 0.08% | 3,735 | 29.41K | Mar 30, 2022 |
